Search

A report from the Swiss Federal Institute of Technology Lausanne (EPFL) discusses the potential for using in-memory sensing and computing in cancer diagnostics. The report examines the use of two-terminal switching devices, known as memristive devices, which have hysteric behavior in current-to-voltage characteristics. These devices have applications in data storage, in-memory computing, and in-sensor computing. The report explores the concept of using multiple cancer markers simultaneously to improve diagnostic processes in cancer medicine. The research was supported by the Swiss National Science Foundation and has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at the Vellore Institute of Technology in Tamil Nadu, India, explores the concept of biographical renewal in cancer survivorship. The study highlights the positive transformations that can occur after cancer and emphasizes the importance of considering biographical renewal as a goal in survivorship care plans. The researchers suggest that healthcare professionals, caregivers, and palliative care providers should strive to foster an understanding of biographical renewal to provide comprehensive care and improve patients' quality of life. The study's findings are published in the Indian Journal of Palliative Care. [Extracted from the article]

Queen's University researchers have developed an educational resource for gynecological cancer survivors and their caregivers. The resource was created through a patient-clinician-researcher partnership and involved five phases, including assembling expertise, reviewing literature, drafting the resource, testing it, and disseminating it. The researchers used diverse partnerships and multiple research methods to create a resource that fills a procedural gap for clinicians and researchers looking to develop empirically and experientially founded educational resources. For more information, readers can refer to the article "Developing an educational resource for gynecological cancer survivors and their caregivers: A methods and experience paper" in the Canadian Oncology Nursing Journal. [Extracted from the article]

Acupath LABORATORIES INC., Biomarkers, Bladder Cancer, Business, Cancer, Cancer Biomarkers, Carcinoma Biomarkers, Cytology, Diagnostics and Screening, Health and Medicine, Oncology, Risk and Prevention Keywords: Acupath LABORATORIES INC.; Biomarkers; Bladder Cancer; Business; Cancer; Cancer Biomarkers; Carcinoma Biomarkers; Cytology; Diagnostics and Screening; Health and Medicine; Oncology; Risk and Prevention EN Acupath LABORATORIES INC. Biomarkers Bladder Cancer Business Cancer Cancer Biomarkers Carcinoma Biomarkers Cytology Diagnostics and Screening Health and Medicine Oncology Risk and Prevention 69 69 1 09/19/23 20230919 NES 230919 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Acupath Labs released a white paper highlighting the impressive results of a large-scale internal study analyzing the clinical utility of its Acu-UR017 bladder cancer biomarker. [Extracted from the article]

Keywords for this news article include: Vienna, Austria, Europe, Allergies, Cancer, Health and Medicine, Immune System Diseases and Conditions, Immunology, Oncology, Risk and Prevention, University of Vienna. Keywords: Vienna; Austria; Europe; Allergies; Cancer; Health and Medicine; Immune System Diseases and Conditions; Immunology; Oncology; Risk and Prevention EN Vienna Austria Europe Allergies Cancer Health and Medicine Immune System Diseases and Conditions Immunology Oncology Risk and Prevention 981 981 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Immune System Diseases and Conditions - Allergies are discussed in a new report. [Extracted from the article]

Keywords for this news article include: Tianjin First Central Hospital, Tianjin, People's Republic of China, Asia, Cancer, Oncology, Health and Medicine. Keywords: Cancer; Health and Medicine; Oncology EN Cancer Health and Medicine Oncology 1114 1114 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New study results on cancer have been published. [Extracted from the article]

Keywords: Cancer; Colorectal Research; Gastric Cancer; Gastroenterology; Health and Medicine; Oncology; Risk and Prevention EN Cancer Colorectal Research Gastric Cancer Gastroenterology Health and Medicine Oncology Risk and Prevention 961 961 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on gastric cancer is the subject of a new report. Cancer, Colorectal Research, Gastric Cancer, Gastroenterology, Health and Medicine, Oncology, Risk and Prevention. [Extracted from the article]

Keywords: Wenzhou; People's Republic of China; Asia; Cancer; Diagnostics and Screening; Electronics; Gastric Cancer; Gastroenterology; Health and Medicine; Oncology; Optoelectronics EN Wenzhou People's Republic of China Asia Cancer Diagnostics and Screening Electronics Gastric Cancer Gastroenterology Health and Medicine Oncology Optoelectronics 561 561 1 06/05/23 20230606 NES 230606 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Gastric Cancer are presented in a new report. Gas chromatography-mass spectroscopy (GC-MS) analysis of the exhaled gas from GC patients and healthy candidates indicated 25 different VOCs which may be used as the biomarkers.". [Extracted from the article]

Keywords: Antibiotics; Antineoplastics; Cancer; Cell Line; Doxorubicin Therapy; Drugs and Therapies; Health and Medicine; Oncology; Pharmaceuticals EN Antibiotics Antineoplastics Cancer Cell Line Doxorubicin Therapy Drugs and Therapies Health and Medicine Oncology Pharmaceuticals 69 69 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on cancer are presented in a new report. The combination of doxorubicin, Baicalein, and resveratrol has resulted in a less cardiotoxic effect compared to treatment with doxorubicin alone." Conclusion: combinations of Baicalein and resveratrol with doxorubicin chemotherapeutic drug In Vitro had enhanced the cytotoxic activity of such a chemotherapeutic drug, while simultaneously eliminating its cardio-toxicity side effect.". [Extracted from the article]

Keywords: Karnataka; India; Asia; Biological Factors; Biological Tumor Markers; Biomarkers; Cancer; Cancer Biomarkers; Carcinoembryonic Antigen; Carcinoma Biomarkers; Cell Adhesion Molecules; Cell Research; Diagnostics and Screening; Emerging Technologies; Enolase; Enzymes and Coenzymes; Glycoproteins; Health and Medicine; Immunology; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Membrane Proteins; Nanotechnology; Neoplasm Antigens; Oncology; Physics; Quantum Dots; Quantum Physics; Tumor Markers EN Karnataka India Asia Biological Factors Biological Tumor Markers Biomarkers Cancer Cancer Biomarkers Carcinoembryonic Antigen Carcinoma Biomarkers Cell Adhesion Molecules Cell Research Diagnostics and Screening Emerging Technologies Enolase Enzymes and Coenzymes Glycoproteins Health and Medicine Immunology Lung Cancer Lung Diseases and Conditions Lung Neoplasms Membrane Proteins Nanotechnology Neoplasm Antigens Oncology Physics Quantum Dots Quantum Physics Tumor Markers 532 532 1 05/15/23 20230516 NES 230516 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Diagnostics and Screening - Cancer Biomarkers have been published. According to the news editors, the research concluded: "This can become a promising diagnostic tool if extended for detection of other proteins or biomarkers involved in environmental and food safety research.". [Extracted from the article]